Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial |
| |
| Authors: | David Power,Ulrich Sch fer,Paul Guedeney,Bimmer E. Claessen,Samantha Sartori,Sabato Sorrentino,Thierry Lef vre,Christian Kupatt,Didier Tchetche,Nicolas Dumonteil,John G. Webb,Antonio Colombo,Stephen Windecker,Jurrië n M. ten Berg,David Hildick‐Smith,Peter Boekstegers,Axel Linke,Christophe Tron,Eric Van Belle,Anita W. Asgar,Raban Jeger,Gennaro Sardella,Ulrich Hink,Oliver Husser,Eberhard Grube,Ilknur Lechthaler,Peter Wijngaard,Prodromos Anthopoulos,Efthymios N. Deliargyris,Debra Bernstein,Christian Hengstenberg,Roxana Mehran,George D. Dangas |
| |
| Affiliation: | David Power,Ulrich Schäfer,Paul Guedeney,Bimmer E. Claessen,Samantha Sartori,Sabato Sorrentino,Thierry Lefèvre,Christian Kupatt,Didier Tchetche,Nicolas Dumonteil,John G. Webb,Antonio Colombo,Stephen Windecker,Jurriën M. ten Berg,David Hildick‐Smith,Peter Boekstegers,Axel Linke,Christophe Tron,Eric Van Belle,Anita W. Asgar,Raban Jeger,Gennaro Sardella,Ulrich Hink,Oliver Husser,Eberhard Grube,Ilknur Lechthaler,Peter Wijngaard,Prodromos Anthopoulos,Efthymios N. Deliargyris,Debra Bernstein,Christian Hengstenberg,Roxana Mehran,George D. Dangas |
| |
| Abstract: | ![]()
|
| |
| Keywords: | BRAVO closure device TAVR vascular complication |
|
|
